Acomplia
|
||
The approval follows extensive and thorough safety information and clinical testing programs involving more than 6,600 participants from many different countries over two years. The testing showed that rimonabant (acomplia) given in 20 milligram daily does helped weight loss, reduced waist measurements and lowered cholestorol and tricycerides. It is stressed that Acomplia is suitable for people who really have a weight problem and is not for people looking for a quick weight loss fix. Acomplia works by blocking the CB1 brain receptors that control the desire to eat and thus reduced appetite.
|
||